Organon develops and provides medicines and health solutions focused on women’s health, biosimilars, and established brands. The company offers treatments for contraception, fertility, menopause, and conditions such as endometriosis, along with therapies addressing cardiovascular and respiratory diseases through its established portfolio. It also develops and commercializes biosimilar products that aim to expand access to biologic treatments. Organon collaborates with healthcare providers, governments, and partners to support education, access, and delivery of care. Its operations include research, manufacturing, and distribution of pharmaceutical products across multiple therapeutic areas.